Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05759481
PHASE2

Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion

Sponsor: Milton S. Hershey Medical Center

View on ClinicalTrials.gov

Summary

The purpose of this study is to clarify whether or not a low-dose propofol infusion can effectively prevent postoperative nausea and vomiting (PONV) in patients who have a documented history of PONV and/or motion sickness.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

65

Start Date

2024-02-01

Completion Date

2025-03-12

Last Updated

2026-08-14

Healthy Volunteers

No

Interventions

DRUG

Hybrid anesthesia (propofol + sevoflurane)

General anesthesia maintained with a continuous low-dose propofol infusion (25 mcg/kg/min) combined with sevoflurane. Anesthetic depth was titrated to a bispectral index (BIS) target of 40-60. No other hypnotic or sedative agents were permitted.

DRUG

Propofol only TIVA

General anesthesia maintained exclusively with intravenous propofol infusion, without the use of volatile anesthetics. Propofol dosing was titrated to maintain a bispectral index (BIS) target of 40-60. No other hypnotic or sedative agents were permitted

Locations (1)

Penn State Health Milton S Hershey Medical Center

Hershey, Pennsylvania, United States